FAFGX | TGCNX | FAFGX / TGCNX | |
Total Expense Ratio | 0.40 | 0.93 | 43% |
Annual Report Gross Expense Ratio | 0.40 | 1.06 | 38% |
Fund Existence | 5 years | 26 years | - |
Gain YTD | 1.305 | 0.648 | 202% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 298B | 698M | 42,693% |
Annual Yield % from dividends | 0.61 | 0.00 | - |
Returns for 1 year | 6.53 | -4.74 | -138% |
Returns for 3 years | 43.48 | 4.48 | 970% |
Returns for 5 years | N/A | -10.31 | - |
Returns for 10 years | N/A | -10.00 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IFTAX | 12.35 | 0.05 | +0.41% |
Voya International High Div Low Vol A | |||
PCBSX | 15.08 | 0.02 | +0.13% |
BlackRock Tactical Opportunities Service | |||
RYCFX | 38.33 | N/A | N/A |
Rydex Biotechnology C | |||
HFDYX | 18.64 | -0.05 | -0.27% |
Hartford Schroders US MidCap Opps Y | |||
NEFFX | 61.81 | -0.42 | -0.67% |
American Funds New Economy F2 |